Health Care & Life Sciences » Pharmaceuticals » Orphan drugs | Global orphan drug revenues top 10 companies 2024 forecast

Top 10 companies by global revenue from orphan drugs 2024

Forecast of top 10 pharmaceutical companies by global orphan drug revenue in 2024 (Figures expressed in billions of U.S. dollars, unless otherwise specified)

The data displays a projection of the top 10 global pharmaceutical companies based on revenue generated by orphan drugs in 2024. For that year, it is projected that Roche's orphan drugs revenue will total 13.5 billion USD. Orphan drugs are used to target rare diseases or disorders, which in the U.S. is defined as less than 200,000 patients. The development of orphan drugs are currently incentivized in the U.S. through the Orphan Drug Act of 1983.

Celgene 18.4
Johnson & Johnson 15
Novartis 14.2
Roche 13.5
Merck & Co 13.4
Bristol-Myers Squibb 11.1
Shire 8.8
AbbVie 8.6
Sanofi 7.4
Alexion Pharmaceuticals 7.2

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.